Targeted disruption of caspase genes in mice: What they tell us about the functions of individual caspases in apoptosis

Immunology and Cell Biology

Volumn 77, Issue 1, 1999, Pages 58-63

  Colussi, Paul A ^a   Kumar, Sharad ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Apaf 1; Apoptosis; Caspases; Cytochrome c; Death receptors; Development; Gene knockout mice; Mitochondria; Programmed cell death

Indexed keywords

CASPASE; CYSTEINE PROTEINASE; CYTOCHROME C;

ANIMAL CELL; APOPTOSIS; ENZYME ACTIVATION; KNOCKOUT GENE; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FAMILY; REVIEW;

EID: 0033026172     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00788.x     Document Type: Review

References (46)

1. 1 Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239-57.
2. 2 Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int. Rev. Cytol. 1980; 68: 251-306.
3. 3 Kumar S. ICE-like proteases in apoptosis. Trends Biochem. Sci. 1995; 20: 198-202.
4. 4 Kumar S, Lavin MF. The ICE family of cysteine proteases as effectors of cell death. Cell Death Diff. 1996; 3: 255-67.
5. 5 Nicholson DW, Thornberry NA. Caspases: Killer proteases. Trends Biochem. Sci. 1997; 22: 299-306.
6. 6 Cryns V, Yuan J. Proteases to die for. Genes Dev. 1998; 12: 1551-70.
7. 7 Green DR. Apoptotic pathways: The roads to ruin. Cell 1998, 94: 695-8.
8. 8 Thornberry NA, Bull HG, Calaycay JR et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992; 356: 768-74.
9. 9 Colussi PA, Harvey NL, Kumar S. Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor: A novel function for a caspase prodomain. J. Biol. Chem. 1998; 273: 24 535-42.
10. 10 Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-65.
11. 11 Ashkenazi A, Dixit VM. Death receptors: Signalling and modulation. Science 1998; 281: 1305-8.
12. 12 Chou JJ, Matsuo H, Duan H, Wagner G. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell 1998; 94: 171-80.
13. 13 Butt AJ, Harvey NL, Parasivam G, Kumar S. Dimerisation and autoprocessing of the Nedd2 (caspase-2) precursor requires both the prodomain and the carboxyl terminal regions. J. Biol. Chem. 1998; 273: 6763-8.
14. 14 Colussi PA, Harvey NL, Shearwin-Whyatt LM, Kumar S. Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J. Biol. Chem. 1998; 273: 26 566-70.
15. 15 Srinivasula SM, Ahmed M, Fernandes-Alnemri T, Liwack G, Alnemri ES. Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-I protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl Acad. Sci. USA 1996; 93: 14 486-91.
16. 16 Stennicke HR, Jurgensmeier JM, Shin H et al. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 1998; 273: 27 084-90.
17. 17 Li P, Nijhawan D, Budihardjo I et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates the apoptotic protease cascade. Cell 1997; 91: 479-89.
18. 18 Hu Y, Benedict MA, Wu D, Inohara N, Nunez G. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl Acad. Sci. USA 1998; 95: 4386-91.
19. 19 Pan G, O'Rourke K, Dixit VM. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J. Biol. Chem. 1998; 273: 5841-5.
20. 20 Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell 1998; 1: 949-57.
21. 21 Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997; 90: 405-13.
22. 22 Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501.
23. 23 Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481-90.
24. 24 Cerretti DP, Kozlosky CJ, Mosley B et al. Molecular cloning of the interleukin-1β converting enzyme. Science 1992; 256: 97-100.
25. 25 Yuan J, Shaham S, Ledoux S, Ellis H, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 1993; 75: 641-52.
26. 26 Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1b-converting enzyme, a mammalian homologue of the C. elegans cell death gene ced-3. Cell 1993; 75: 653-60.
27. 27 Kuida K, Lippke JA, Ku G et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1beta converting enzyme. Science 1995; 267: 2000-3.
28. 28 Li P, Allen H, Banerjee S et al. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxin shock. Cell 1995; 80: 401-11.
29. 29 Wang S, Miura M, Bergeron L, Zhu H, Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998; 92: 501-9.
30. 30 Wang S, Miura M, Jung Y et al. Identification and characterization of Ich-3, a member of the interleukin-1beta converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J. Biol. Chem. 1996; 271: 20 580-7.
31. 31 Hengartner MO. Cell death. In: Riddle DL, Blumanthal T, Meyer BJ, Priess JR (eds) C. elegans II. Plainview NY: Cold Spring Harbor Laboratory Press, 1997; 383-415.
32. 32 Chinnaiyan AM, O'Rourke K, Lane BR, Dixit VM. Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 1997; 275: 1122-6.
33. 33 Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-6.
34. 34 Kuida K, Zheng TS, Na S et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384: 368-72.
35. 35 Woo M, Hakem R, Soengas MS et al. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 1998; 12: 806-19.
36. 36 Kuida K, Haydar TF, Kuan CY et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998; 94: 325-37.
37. 37 Hakem R, Hakem A, Duncan GS et al. Differential requirement for caspase-9 in apoptotic pathways in vivo. Cell 1998; 94: 339-52.
38. 38 Yoshida H, Kong YY, Yoshida R et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 1998; 94: 739-50.
39. 39 Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 1998; 94: 727-37.
40. 40 Duan H, Dixit VM. RAIDD is a new 'death' adaptor molecule. Nature 1997; 385: 86-90.
41. 41 Varfolomeev EE, Schuchmann M, Luria V et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998; 9: 267-76.
42. 42 Yeh WC, Pompa JL, McCurrach ME et al. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998; 279: 1954-8.
43. 43 Zhang J, Cado D, Chen A, Kabra NH, Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998; 392: 296-9.
44. 44 Newton K, Harris AW, Bath ML, Smith KGC, Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 1998; 17: 706-18.
45. 45 Bergeron L, Perez GI, Macdonald G et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 1998; 12: 1304-14.
46. 46 Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 1998; 8: 297-303.